Skip to main content

Table 2 Clinical and Histopathological Characteristics

From: Pharmacokinetic parameters and radiomics model based on dynamic contrast enhanced MRI for the preoperative prediction of sentinel lymph node metastasis in breast cancer

  Patients with positive SLN (n = 78) Patients with negative SLN(n = 86) p value
Age (mean ± SD) 55.71 ± 8.6 54.40 ± 11.1 0.483
Tumor size (mean ± SD) 2.24 ± 1.0 2.21 ± 1.2 0.698
Histological grade    0.171
 I 4 (5.15%) 25 (11.6%)  
 II 33 (42.3%) 41 (47.7%)  
 III 41 (52.6%) 20 (40.7%)  
Molecular subtype    0.220
 Luminal A 30 (38.5%) 31 (36%)  
 Luminal B 37 (47.4%) 33 (38.4%)  
HER2 over-expression 6 (7.7%) 8 (9.3%)  
Basal-like 5 (6.4%) 14 (16.3%)